#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stargardt's disease Gastrointestinal disorder Rhabdomyosarcoma Gastrointestinal neuroendocrine tumour Necrotising enterocolitis neonatal Liver abscess Thrombocytosis Follicle centre lymphoma follicular grade I, II – III Hyperchylomicronaemia Systemic candida HER2 gene amplification Immunodeficiency congenital Ovarian epithelial cancer Chronic myelomonocytic leukaemia Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Primary biliary cholangitis – Trials in Disease Ewing’s sarcoma recurrent – Treatment Systemic mastocytosis – Treatment Testicular leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Life with Disease Lymphangioma – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Mucopolysaccharidosis II – Diagnostics Mucopolysaccharidosis III – Basic Information More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    S227928 Spesolimab Imipenem Dextromethorphan Hydrobromide Lisdexamfetamine Dimesylate Pembrolizumab Trimetazidine Dihydrochloride Alxn1850 AVTX-009 Hypromellose Rimegepant Clebopride Hydrogen Maleate Propafenone Hydrochloride Trametinib Dimethyl Sulfoxide Treosulfan Vosoritide Dexamethasone Ph. Eur. Patritumab Deruxtecan Tanimilast Keto-Leucine Calcium More therapies…

    Learn about Your Condition

    Anogenital warts Corneal dystrophy Primary hyperoxaluria Ejection fraction normal Andersen-Tawil syndrome Colorectal cancer metastatic Hydrocele ROHHAD syndrome Uveal melanoma Postprandial hypoglycaemia Transient ischaemic attack Urethral stenosis Radicular pain Respiratory distress Onychomycosis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms

    Recruiting

    2 1 1
    Investigated diseases:
    • Childhood asthma
    • Asthma
    Investigated drugs:
    • Hydroxypropyl Cellulose Lf
    • Sodium Phosphate Dodecahydrate
    • Xanthum Gum
    Denmark
  • Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1 1
    Investigated drugs:
    • Humanised Igg1 Kappa Monoclonal Antibody Against Alfa4Beta7 Integrin
    • ABBV-8736
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated diseases:
    • Major depression
    Norway
  • Effect of dry extract from Psilocybe cubensis (15‑25:1), extraction solvent methanol, with psychotherapy versus basic support on depressive symptoms in adults with depression

    Not yet recruiting

    2 1 1
    Investigated diseases:
    • Depression
    Investigated drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Denmark
  • Phase 1b-2 Study of Safety and Preliminary Efficacy of LRK-4189 Alone or with Drug Combination in Patients with Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Colorectal cancer
    Investigated drugs:
    • Folinic Acid
    • Fluorouracil
    • Irinotecan
    France
  • Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Squamous cell carcinoma of lung
    Investigated drugs:
    • Cemiplimab
    Italy
Previous Page
1 … 649 650 651 652 653 … 1,616
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!